I Vergote

发表

Balancing false positives and false negatives for the detection of differential expression in malignancies

F De Smet, Y Moreau, K Engelen, 2004, British Journal of Cancer.

T2-weighted MR imaging of the uterus: comparison of optimized fast spin-echo and HASTE sequences with conventional fast spin-echo sequences.

A L Baert, H Bosmans, I Vergote, 1998, AJR. American journal of roentgenology.

A scoring system for immunohistochemical staining: consensus report of the task force for basic research of the EORTC-GCCG. European Organization for Research and Treatment of Cancer-Gynaecological Cancer Cooperative Group.

I Vergote, P. V. van Diest, E. Berns, 1997, Journal of clinical pathology.

Large-scale genomic instability predicts long-term outcome for women with invasive stage I ovarian cancer.

I Vergote, H E Danielsen, V. Abeler, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Ovarian cancer prediction in adnexal masses using ultrasound‐based logistic regression models: a temporal and external validation study by the IOTA group

S Van Huffel, D Timmerman, I Vergote, 2010, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

A comparison of methods for preoperative discrimination between malignant and benign adnexal masses: the development of a new logistic regression model.

W P Collins, D Timmerman, I Vergote, 1999, American journal of obstetrics and gynecology.

HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm

D Timmerman, I Vergote, B De Moor, 2011, British Journal of Cancer.

Strategies to diagnose ovarian cancer: new evidence from phase 3 of the multicentre international IOTA study

D Timmerman, I Vergote, L Wynants, 2014, British Journal of Cancer.

Prognostic nomogram to predict progression-free survival in patients with platinum-sensitive recurrent ovarian cancer

B Richter, I Vergote, V. Gebski, 2011, British Journal of Cancer.

Timing of debulking surgery in advanced ovarian cancer

I Vergote, K Leunen, P. Neven, 2008, International Journal of Gynecologic Cancer.

Artificial neural network models for the preoperative discrimination between malignant and benign adnexal masses

J Vandewalle, W P Collins, D Timmerman, 1999, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

Re: Mol et al. Distinguishing the benign and malignant adnexal mass: an external validation of prognostic models. Gynecol Oncol 2001;80:162-7.

W P Collins, D Timmerman, I Vergote, 2001, Gynecologic oncology.

Fulvestrant, a new treatment option for advanced breast cancer: tolerability versus existing agents.

I Vergote, I. Vergote, P Abram, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

The molecular genetic basis of ovarian cancer and its roadmap towards a better treatment.

I Vergote, P. Neven, D. Lambrechts, 2010, Gynecologic oncology.